Literature DB >> 10954068

Autonomic dysfunction in Machado-Joseph disease assessed by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy.

T Kazuta1, M Hayashi, T Shimizu, A Iwasaki, S Nakamura, S Hirai.   

Abstract

Iodine123-labeled metaiodobenzylguanidine, a radioiodinated analogue of norepinephrine, is a tracer for evaluating sympathetic function. We used iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy and sympathetic skin response to study autonomic nervous functions in 19 patients with Machado-Joseph disease (MJD) and 20 control subjects. Planar imaging of all the participants was done to evaluate myocardial scintigraphy. The ratio of average counts in the heart to average counts in the mediastinum was calculated for both early and delayed images, the latter of which reflects the cardiac neural uptake of the tracer. Single photon emission computed tomography also was done on 12 patients with MJD to examine regional tracer uptake to the heart. The mean ratio of counts in the heart to counts in the mediastinum in the delayed images was lower for the patients with MJD than for the control subjects (p <0.01). Abnormal sympathetic skin response was present in 6 patients with MJD whose mean ratio of counts in the heart to counts in the mediastinum was lower than that of patients with MJD who had normal sympathetic skin response (p <0.01). A single photon emission computed tomography study showed significantly lower accumulation of the tracer in patients with MJD than in the control subjects in the anterior lateral sectors predominantly innervated by sympathetic nerves but not in the inferior septal sectors reported to be under main innervation by parasympathetic fibers. These results show that MJD is accompanied by cardiac sympathetic dysfunction, as detected by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy, which appears to be correlated with sudomotor sympathetic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954068     DOI: 10.1007/bf02278014

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  16 in total

1.  Machado-Joseph disease: cerebellar ataxia and autonomic dysfunction in a patient with the shortest known expanded allele (56 CAG repeat units) of the MJD1 gene.

Authors:  Y Takiyama; K Sakoe; I Nakano; M Nishizawa
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

2.  Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.

Authors:  M Yoshita
Journal:  J Neurol Sci       Date:  1998-02-18       Impact factor: 3.181

3.  Scintigraphic assessment of regional cardiac adrenergic innervation.

Authors:  M W Dae; J W O'Connell; E H Botvinick; T Ahearn; E Yee; J P Huberty; H Mori; M C Chin; R S Hattner; J M Herre
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

4.  Pain-related and electrically stimulated somatosensory evoked potentials in patients with Machado-Joseph disease and multiple system atrophy.

Authors:  M Yamamoto; T Kachi; G Sobue
Journal:  Intern Med       Date:  1997-08       Impact factor: 1.271

5.  Myocardial imaging with a radioiodinated norepinephrine storage analog.

Authors:  D M Wieland; L E Brown; W L Rogers; K C Worthington; J L Wu; N H Clinthorne; C A Otto; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-01       Impact factor: 10.057

6.  Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.

Authors:  J C Sisson; B Shapiro; L Meyers; S Mallette; T J Mangner; D M Wieland; J V Glowniak; P Sherman; W H Beierwaltes
Journal:  J Nucl Med       Date:  1987-10       Impact factor: 10.057

7.  Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.

Authors:  M Nakajo; B Shapiro; J Glowniak; J C Sisson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1983-12       Impact factor: 10.057

8.  Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy.

Authors:  J S Gill; G J Hunter; G Gane; A J Camm
Journal:  Am Heart J       Date:  1993-08       Impact factor: 4.749

Review 9.  A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG).

Authors:  K K Solanki; J Bomanji; J Moyes; S J Mather; P J Trainer; K E Britton
Journal:  Nucl Med Commun       Date:  1992-07       Impact factor: 1.690

10.  Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine.

Authors:  M Mäntysaari; J Kuikka; J Mustonen; K Tahvanainen; E Vanninen; E Länsimies; M Uusitupa
Journal:  Diabetes       Date:  1992-09       Impact factor: 9.461

View more
  6 in total

1.  Dysautonomia is frequent in Machado-Joseph disease: clinical and neurophysiological evaluation.

Authors:  Karen A G Takazaki; Anelyssa D'Abreu; Anamarli Nucci; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

2.  Reduced cardiac 123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson's disease.

Authors:  Anna De Rosa; Sabina Pappatà; Teresa Pellegrino; Maria Fulvia De Leva; Gennaro Maddaluno; Giovanni Fiumara; Raffaella Carotenuto; Mario Petretta; Alessandro Filla; Giuseppe De Michele; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-09       Impact factor: 9.236

3.  Altered heart rate control in response to postural change in patients with Machado-Joseph disease (SCA3).

Authors:  Yu Koyama; Masato Asahina; Koiti Honma; Kimihito Arai; Takamichi Hattori
Journal:  Cerebellum       Date:  2009-06       Impact factor: 3.847

Review 4.  Nonmotor symptoms in spinocerebellar ataxias (SCAs).

Authors:  Adriana Moro; Mariana Moscovich; Marina Farah; Carlos Henrique F Camargo; Hélio A G Teive; Renato P Munhoz
Journal:  Cerebellum Ataxias       Date:  2019-08-27

Review 5.  The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.

Authors:  Fabian Leys; Gregor K Wenning; Alessandra Fanciulli
Journal:  Neurol Sci       Date:  2021-11-24       Impact factor: 3.830

6.  Autonomic dysfunction as the initial presentation in spinocerebellar ataxia type 3: A case report and review of the literature.

Authors:  Yi Jin; Yuchao Chen; Dan Li; Mengqiu Qiu; Menglu Zhou; Zhouyao Hu; Qiusi Cai; Xulin Weng; Xiaodong Lu; Bin Wu
Journal:  Front Neurol       Date:  2022-09-27       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.